{
  "trial_id": "NCT00602641",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "confirmed diagnosis of symptomatic myeloma",
      "label": "met",
      "evidence": "patient text"
    },
    {
      "criterion": "bone marrow plasmacytosis with >= 10% plasma cells or sheets of plasma cells",
      "label": "met",
      "evidence": "patient text"
    },
    {
      "criterion": "symptomatic disease at initial diagnosis that prompted the initiation of therapy",
      "label": "met",
      "evidence": "patient text"
    },
    {
      "criterion": "end-organ damage at the time of diagnosis",
      "label": "met",
      "evidence": "patient text"
    },
    {
      "criterion": "age > 65 and declined alternative treatment",
      "label": "met",
      "evidence": "patient text"
    },
    {
      "criterion": "ECOG performance status =< 2",
      "label": "met",
      "evidence": "patient text"
    },
    {
      "criterion": "serum free light chain assay performed within 28 days prior to randomization",
      "label": "met",
      "evidence": "patient text"
    },
    {
      "criterion": "kappa free light chain performed within 28 days prior to randomization",
      "label": "met",
      "evidence": "patient text"
    },
    {
      "criterion": "lambda free light chain performed within 28 days prior to randomization",
      "label": "met",
      "evidence": "patient text"
    },
    {
      "criterion": "urine protein electrophoresis (UPEP) performed within 28 days prior to randomization",
      "label": "met",
      "evidence": "patient text"
    },
    {
      "criterion": "hemoglobin > 7 g/dL",
      "label": "met",
      "evidence": "patient text"
    },
    {
      "criterion": "platelet count > 75,000 cells/mm^3",
      "label": "met",
      "evidence": "patient text"
    },
    {
      "criterion": "absolute neutrophil count > 1000 cells/mm^3",
      "label": "met",
      "evidence": "patient text"
    }
  ],
  "exclusion": [
    {
      "criterion": "",
      "label": "unknown",
      "evidence": ""
    }
  ],
  "notes": "Patient has multiple myeloma with recurrent disease and systemic amyloidosis. She is on hemodialysis for ESRD and has been treated with various therapies, including melphalan, prednisone, VAD regimen, autologous stem cell transplant, thalidomide, and velcade.",
  "_meta": {
    "topic_id": "17",
    "trial_id": "NCT00602641",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}